Viatris

Phone: +17245141800

Web: https://www.viatris.com/

Type	Public
Traded as	Nasdaq: VTRS S&P 500 component
ISIN	US92556V1061
Industry	Pharmaceuticals Healthcare
Predecessors	Mylan Upjohn
Founded	November 16, 2020 (2020-11-16)
Headquarters	Canonsburg, Pennsylvania, U.S.
Area served	Worldwide
Key people	Robert J. Coury (Executive Chairman) Michael Goettler (CEO) Sanjeev Narula (CFO) W. Don Cornwell (Director) James M. Kilts (Director) Ian Read (Director)
Products	Medicines generic drugs biosimilars active pharmaceutical ingredients
Revenue	US$17.89 billion (2021)
Net income	US$−1.27 billion (2021)
Total assets	US$54.84 billion (2021)
Total equity	US$20.49 billion (2021)
Number of employees	c. 37,000 (December 2021)
Website	viatris.com

At Viatris, we have one of the strongest global commercial infrastructures in the industry, with a balanced reach across North America, Europe, the Asia Pacific region and emerging markets. Our high quality global manufacturing, scientific excellence and vast supply chain network mean we are uniquely positioned to improve access to medicine for patients worldwide.

For detailed contact information visit location pages below.